Home › Trial NCT06262789
RAT-HEMATO : Return to Work After Malignant Hemopathy
- Trial IDNCT06262789
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity Hospital, Angers
- Enrollment264
- Start date2024-09-27
- ConditionsLeukemia · Lymphoma · Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.